Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs
Healthcare Law Insights blog
JUNE 30, 2023
FDA notes that “typical” animal toxicology testing may not be necessary where there is already “extensive human exposure and information are available from previously conducted clinical studies and no serious safety concerns were identified.” For one, the use of an inert placebo may present a challenge.
52 
Let's personalize your content